Tag: equity
-
Engineered Cell Therapy Company Issues $588M IPO
A company developing regenerative therapies with engineered stem cells for cancer and other diseases is raising $587.5 million in its initial public offering or IPO.
-
Cannabidiol Drug Maker Acquired in $7.2B Deal
A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal.
-
Cancer Immunotherapy Adapted for HIV
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections.
-
Investors Raise $1.85B for Biotech Start-Ups
A venture capital company investing in life science and health care businesses raised $1.85 billion to finance biotechnology start-ups.
-
Food Allergy Biotech Raises $40M in New Funds
A biotechnology company designing proteins in food products and therapies for people with food allergies is raising $40 million in its second venture round.
-
Crispr Heart Disease Biotech Raises $94M in New Funds
A company applying Crispr gene-editing technology to treat inherited heart disease is raising $94 million in its second venture funding round.
-
2020 Venture Funds Mixed, Biotech Keeps Sizzling
Total venture investments in dollars jumped to a new high in the U.S., while biotechnology remained the single hottest sector in 2020.
-
Drug Price Disruptor Biotech Raises $500M in New Funds
A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round.
-
Synthetic Biology Company Raises $105M in New Funds
A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round.
-
Synthetic Virus Company Forms, Raises $77M
A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute.